Unbound MEDLINE

Articles related to 11432089 journal articles from PubMed MEDLINE database

Unbound MEDLINE results for:Bookmark this site
Articles related to 11432089 [Unique ID], provided by the PubMed system
1 - 10 of 176 journal articles in the PubMed databaseEmail to a friend    
 
Espinola-Zavaleta N, Yánac-Chávez P, Vargas-Barrón J, et al. 
[Safety and efficiency of Echogen. Transthoracic echocardiography study] [Clinical Trial, Clinical Trial, Phase III, English Abstract, Journal Article, Multicenter Study]
Gac Med Mex 2001 May-Jun; 137(3):203-8.
Abstract | Full Citation | Find Related Articles 
Grayburn PA, Weiss JL, Hack TC, et al. 
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study]
J Am Coll Cardiol 1998 Jul; 32(1):230-6.
Abstract | Full Citation | Find Related Articles 
Hundley WG, Kizilbash AM, Afridi I, et al. 
Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Am Coll Cardiol 1998 Nov; 32(5):1426-32.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Beppu S, Matsuda H, Shishido T, et al. 
Prolonged myocardial contrast echocardiography via peripheral venous administration of QW3600 injection (EchoGen): its efficacy and side effects. [Journal Article]
J Am Soc Echocardiogr 1997 Jan-Feb; 10(1):11-24.
Abstract | Full Citation | Find Related Articles 
Kitzman DW, Goldman ME, Gillam LD, et al. 
Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Am J Cardiol 2000 Sep 15; 86(6):669-74.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
McMahon CJ, Ayres NA, Bezold LI, et al. 
Safety and efficacy of intravenous contrast imaging in pediatric echocardiography. [Journal Article]
Pediatr Cardiol 2005 Jul-Aug; 26(4):413-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Cohen JL, Cheirif J, Segar DS, et al. 
Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study]
J Am Coll Cardiol 1998 Sep; 32(3):746-52.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Crouse LJ, Cheirif J, Hanly DE, et al. 
Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study]
J Am Coll Cardiol 1993 Nov 1; 22(5):1494-500.
Abstract | Full Citation | Find Related Articles 
Dittmann H, Razwan E, Greis C, et al. 
[Improved assessment of the left ventricular endocardial border by intravenous injection of a left heart contrast agent] [Clinical Trial, Clinical Trial, Phase II, Journal Article]
Ultraschall Med 1999 Oct; 20(5):185-90.
Abstract | Full Citation | Find Related Articles 
New Search Next Results
  

Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo


Advertise on this site.